Investor/Media Center

print page

Press Releases

 


Displaying releases: 1-40 | 41-80 | 81-120 | 121-160 | 161-200 | 201-207


Jul-06-2015 Palatin Technologies Completes $30 Million Financing
May-13-2015 Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2015 Results
May-08-2015 Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2015 Results
Mar-06-2015 Palatin Technologies to Present at the 27th Annual ROTH Conference
Feb-20-2015 Palatin Launches reconnectstudy.com in Support of Bremelanotide Phase 3 Program for Female Sexual Dysfunction
Feb-13-2015 Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on February 13, 2015
Feb-09-2015 Palatin Technologies, Inc. To Report Second Quarter Fiscal Year 2015 Results Teleconference and Webcast to be held on February 13, 2015
Feb-06-2015 PALATIN TECHNOLOGIES TO PRESENT AT THE BIO CEO & INVESTOR CONFERENCE
Dec-29-2014 Palatin Announces Start of Bremelanotide Phase 3 Program For Female Sexual Dysfunction
Dec-24-2014 Palatin Completes $20 Million Equity and $10 Million Debt Financings
Nov-18-2014 Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014
Nov-13-2014 Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2015 Results
Oct-08-2014 Palatin Technologies To Present At The 13th Annual Bio Investor Forum
Sep-09-2014 Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2014 Results
Sep-04-2014 Palatin Technologies, Inc. To Report Fourth Quarter and Fiscal Year 2014 Results Teleconference and Webcast to be held on September 9, 2014
Sep-03-2014 Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter
Jul-09-2014 Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
Jun-27-2014 Palatin Technologies to Join Russell Microcap Index
Jun-10-2014 Palatin Technologies Announces Notification of Patent Allowance On Next Generation Melanocortin Receptor-Specific Peptides
May-13-2014 Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on May 13, 2014
May-09-2014 Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2014 Results Teleconference and Webcast to be held on May 13, 2014
May-06-2014 Palatin Technologies Presents at the American Psychiatric Association (APA)
May-01-2014 Palatin Technologies Announces Option Exercise by Specialty Pharmaceutical Company to License Bremelanotide in Europe
Apr-29-2014 Palatin Technologies Presents at the Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG)
Mar-31-2014 Palatin Technologies Announces Option Extension for License to Bremelanotide in Europe
Mar-06-2014 Palatin Technologies to present at the 26th Annual ROTH Conference
Feb-24-2014 Palatin Technologies Presents Positive New Data Analyses Demonstrating Efficacy of Bremelanotide in Female Hypoactive Sexual Desire Disorder
Feb-18-2014 Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on February 18, 2014
Feb-13-2014 Palatin Technologies, Inc. To Report Second Quarter Fiscal Year 2014 Results Teleconference and Webcast to be held on February 18, 2014
Jan-30-2014 Palatin Technologies to Present at the 16th Congress of the European Society for Sexual Medicine
Jan-23-2014 Palatin Technologies, Inc. Receives $1.85 Million from Sale of New Jersey State Tax Credits
Jan-16-2014 Palatin Technologies to Present at “TEN”, Noble Financial Capital Markets’ Tenth Annual Equity Conference
Jan-13-2014 Palatin Technologies Responds to Unusual Market Activity
Dec-02-2013 Palatin Technologies To Participate In The 25th Annual Piper Jaffray Healthcare Conference
Nov-14-2013 Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
Nov-13-2013 Palatin Technologies Announces Option for License to Bremelanotide in Europe
Nov-12-2013 Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
Nov-11-2013 Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results Teleconference and Webcast to be held on November 14, 2013
Oct-28-2013 Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
Oct-04-2013 PALATIN TECHNOLOGIES TO PRESENT AT THE 12TH ANNUAL BIO INVESTOR FORUM